menu search

Opthea to present at the jmp securities life sciences conference

MELBOURNE, Australia, May 08, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing nov...

May 8, 2023, 5:30 am


Search within

Pages Search Results: